FDA Denies Bayer Petition For Aspirin As Primary Prevention Of Heart Attack, Stroke

Aspirin’s potential to prevent a first stroke or heart attack if used regularly does not outweigh the risks, including increased bleeding in the stomach and brain, FDA tells Bayer Healthcare in a letter denying the firm’s request to market the drug for primary prevention.